Cibc Private Wealth Group, LLC Intellia Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 5,880 shares of NTLA stock, worth $129,712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,880
Previous 4,581
28.36%
Holding current value
$129,712
Previous $126,000
3.97%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NTLA
# of Institutions
326Shares Held
88.8MCall Options Held
673KPut Options Held
865K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$256 Million2.36% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$212 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.1MShares$201 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$106 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$96.2 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.68B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...